Welcome visitor Log In - or - Register
(
0 items /
$0.00
)
View Cart
Check Out
four ways
Quick Search:
Skip Navigation LinksHome > Immunosuppressants/Immunochemotherapy Agents > Darovasertib (NVP-LXS196)
Darovasertib (NVP-LXS196)
Darovasertib (NVP-LXS196) is an orally bioavailable, potent, and selective protein kinase C inhibitor. It is currently in trials for metastatic uveal melanoma.
Catalog NO: CT-LXS196
Synonym: Darovasertib, LXS-196
CAS NO: 1874276-76-2
Mol. Formula: C22H23F3N8O
MW: 472.5
** in vivo Quality Material. 99.9% Pure by HPLC, recrystallized yellow powder (Pic attached). Free base (salt-free), validated by a spot-on quantitative microanalysis. Bulk (discounted price for 0.5G, 1G, 2G)! Same day shipping.